International Stem Cell Corporation
ISCO
$0.11
-$0.001-0.90%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -209.00K | -678.00K | -684.00K | -311.00K | -131.00K |
| Total Depreciation and Amortization | 206.00K | 200.00K | 194.00K | 192.00K | 194.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 825.00K | 918.00K | 957.00K | 906.00K | 869.00K |
| Change in Net Operating Assets | -809.00K | -192.00K | -414.00K | -267.00K | -3.00K |
| Cash from Operations | 13.00K | 248.00K | 53.00K | 520.00K | 929.00K |
| Capital Expenditure | -166.00K | -165.00K | -142.00K | -73.00K | -80.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.00K | -6.00K | -3.00K | -4.00K | -3.00K |
| Cash from Investing | -171.00K | -171.00K | -145.00K | -77.00K | -83.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -200.00K | -200.00K | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -200.00K | -200.00K | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -358.00K | -123.00K | -92.00K | 443.00K | 846.00K |